GSK2646264, a Spleen Tyrosine Kinase Inhibitor Attenuates the Release of Histamine in Ex Vivo Human Skin

British Journal of Pharmacology - United States
doi 10.1111/bph.14610
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

A Spleen Tyrosine Kinase Inhibitor Reduces the Severity of Established Glomerulonephritis

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis

New England Journal of Medicine
Medicine
2010English

Evaluation of a Tyrosine Kinase Peptide Microarray for Tyrosine Kinase Inhibitor Therapy Selection in Cancer

Experimental & Molecular Medicine
2016English

Effects of a Skin-Massaging Device on the Ex-Vivo Expression of Human Dermis Proteins and In-Vivo Facial Wrinkles

PLoS ONE
Multidisciplinary
2017English

Ibrutinib: The First Bruton's Tyrosine Kinase Inhibitor

Prescriber
Pharmacology
2018English

The Tyrosine Kinase Inhibitor Genistein Blocks HIV-1 Infection in Primary Human Macrophages

Virus Research
Cancer ResearchVirologyInfectious Diseases
2007English

The Tyrosine Kinase Inhibitor Bafetinib Inhibits PAR2-induced Activation of TRPV4 Channelsin Vitroand Painin Vivo

British Journal of Pharmacology
Pharmacology
2014English

An Ex Vivo Human Skin Model to Study Superficial Fungal Infections

Frontiers in Microbiology
Microbiology
2019English

An Ex Vivo Porcine Spleen Perfusion as a Model of Bacterial Sepsis_suppl

Altex
MedicineMedical Laboratory TechnologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy